|
|
 |
|

Yesterday, Apple named Arthur D. Levinson, Ph.D. as the Company’s non-executive Chairman of the Board. Levinson has been a co-lead director of Apple’s board since 2005, has served on all three board committees (audit and finance, nominating and corporate governance, and compensation), and will continue to serve on the audit committee. Apple also announced that Robert A. Iger, President and Chief Executive Officer of The Walt Disney Company, will join Apple’s board and will serve on the audit committee.
Levinson is chairman of Genentech, and a member of the Roche Board of Directors. He joined Genentech as a research scientist in 1980, and served as Genentech’s Chief Executive Officer from 1995 to 2009. He is also a director of Amyris, NGM Biopharmaceuticals, and the Broad Institute of MIT and Harvard. Levinson currently serves on the Board of Scientific Consultants of the Memorial Sloan-Kettering Cancer Center and the Advisory Council for the Lewis-Sigler Institute for Integrative Genomics. He has authored or co-authored more than 80 scientific articles and has been a named inventor on 11 United States patents. In 2008, he was elected to the American Academy of Arts & Sciences. Levinson received his Bachelor of Science degree from the University of Washington and earned a doctorate in Biochemical Sciences from Princeton University.
|
Post a Comment